Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mesoblast Limited (MEOBF)
OTHER OTC:MEOBF
Mesoblast Limited (MEOBF) Stock Price & Analysis
19 Followers
MEOBF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.10 - $0.95
Previous Close$0.53
Volume1.00
Average Volume (3M)359.94K
Market Cap
$607.78M
Enterprise Value$652.76M
Total Cash (Recent Filing)$71.51M
Total Debt (Recent Filing)$116.50M
Price to Earnings (P/E)-5.0
Beta0.85
Next Earnings
May 29, 2024EPS Estimate
-$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding1,140,711,751
10 Day Avg. Volume300,378
30 Day Avg. Volume359,935
Standard Deviation0.29
R-Squared0.10
Alpha-0.00126
Financial Highlights & Ratios
Price to Book (P/B)-2.48
Price to Sales (P/S)91.25
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue115.59
Enterprise Value/Gross Profit87.02
Enterprise Value/Ebitda-14.23
Forecast
1Y Price Target
$0.52Price Target Upside-13.33% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Mesoblast Limited News
PremiumCompany Announcements
Mesoblast Director Buys Shares On-Market
PremiumCompany Announcements
Mesoblast Limited Issues Employee Incentive Options
PremiumCompany Announcements
Mesoblast Reports Lapse of 80,000 Options
Ownership Overview
7.31% Insiders
2.15% Mutual Funds
1.31% Other Institutional Investors
89.22% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MEOBF FAQ
What was Mesoblast Limited’s price range in the past 12 months?
Mesoblast Limited lowest stock price was $0.10 and its highest was $0.95 in the past 12 months.
What is Mesoblast Limited’s market cap?
Currently, no data Available
When is Mesoblast Limited’s upcoming earnings report date?
Mesoblast Limited’s upcoming earnings report date is May 29, 2024 which is in 34 days.
How were Mesoblast Limited’s earnings last quarter?
Mesoblast Limited released its earnings results on Feb 28, 2024. The company reported -$0.038 earnings per share for the quarter, missing the consensus estimate of -$0.025 by -$0.013.
Is Mesoblast Limited overvalued?
According to Wall Street analysts Mesoblast Limited’s price is currently Overvalued.
Does Mesoblast Limited pay dividends?
Mesoblast Limited does not currently pay dividends.
What is Mesoblast Limited’s EPS estimate?
Mesoblast Limited’s EPS estimate is -$0.02.
How many shares outstanding does Mesoblast Limited have?
Mesoblast Limited has 1,141,784,000 shares outstanding.
What happened to Mesoblast Limited’s price movement after its last earnings report?
Mesoblast Limited reported an EPS of -$0.038 in its last earnings report, missing expectations of -$0.025. Following the earnings report the stock price went down -5%.
Which hedge fund is a major shareholder of Mesoblast Limited?
Currently, no hedge funds are holding shares in MEOBF
---
Mesoblast Limited Stock Smart Score
Company Description
Mesoblast Limited
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.
---
MEOBF Company Deck
---
MEOBF Earnings Call
Q2 2024
0:00 / 0:00
---
MEOBF Stock 12 Months Forecast
Average Price Target
$0.52
▼(-13.33% Downside)
Technical Analysis
Best Analysts Covering MEOBF
1 Year
1 Year Success Rate
1/6 ratings generated profit
1 Year Average Return
-38.40%
reiterated a buy rating 10 months ago
Copying John Hester's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -38.40% per trade.
---